Biotech sector operations in June
19/06/2015
Diego Gutiérrez
Biotech sector operations in June
So far in June, two Spanish biotech companies have completed financing rounds, Histocell and Biótica, which supports the conclusion reached by experts in the sector on cyt 60 minutes. "The 21st century will be the century of biotechnology with more than 500 companies created in the sector in the first decade".

 

 

 

Histocell closes a $$2.5M round

The Basque biopharmaceutical company  Histocell, a specialist in regenerative medicine and cell therapy, has closed a round of capital increase 2.5 million for the launch of its healing product on the international market at the end of 2015. Reoxcare.

This is the first of the financing rounds that Histocell plans to carry out in its 2015-2020 strategic plan, but the investment needs reach four million euros, which will be used primarily to complete the development of three medical devices and finalise the clinical phases of two cellular medicines.

 Histocell's main shareholders have participated in the round, including Orza EIG, investment vehicle of ElkarkidetzaGestión de Capital Riesgo del País Vasco and the Group IMQHe has also joined Seed Capital Bizkaia as a new BI partner.
For the time being, the company has already reached agreements for the marketing of Reoxcare in different European and Asian markets, such as the one signed with the company Luqa Pharma for China, Hong Kong and Macao.

Biotica closes financing round

The technology-based company Biótica, has closed a round that has been attended by Caixa Capital Riscthrough the Caixa Capital Micro II fund, the ComVal Emprende fund, managed by Clave Mayor and previous shareholders such as the promoter partners Adrián Fortuño, Guillermo Rodríguez and Iproma (Gimeno Group).

The funds raised will enable Biotica to boost the commercial launch of its online legionella detection system, Legiolab.

The technology company, located in the Science, Technology and Business Park of the Jaume I University of Castellón, is dedicated to the development and commercialisation of systems for the rapid detection of pathogenic microorganisms. It currently has several products in the commercialisation phase, such as the test LEGIPID and CLEANPID, both of which are marketed internationally.

Biotechnology scenario in Spain

 Cristina Garmendia, president of the Cotec Foundation for Technological Innovation and former Minister for Science and Innovation; Regina Revilla, President of the Spanish Association of Biocompanies (Asebio)and Andrés Ballesteros, CEO and founder of the company Vivia Biotech talkedat the third debate on theS&T in 60 minuteson the past, present and future of biotechnology.

Among the main conclusions reached, we can highlight that the 21st century is the century of biotechnology in Spain, with a prodigious first decade, with more than 500 companies having been created in the last 15 years, a figure that places Spain, as Revilla confirmed, "as one of the countries that has created the most biotech companies this century".

In addition, international venture capital looks very favourably on the Spanish biotech sector, something that was not the case years ago. The three speakers agreed that the financial environment needs to be developed more and better so that venture capital enters Spain, settles in, and can leave easily when its presence in business development is no longer necessary.

If you are looking for financing, both public and private, please contact us on +34. 946424142. Abra-Invest has a team with extensive experience in both fields.

Other posts that may interest you

Biotech investment news: Era Biotech, Aura Bioscience, Quirumed and others (March 2015)

Operations Biotechnology February 2015

 

 

Lastest news

Últimas transacciones del sector Cybersecurity

El sector de la ciberseguridad ha sido testigo de una importante oleada de adquisiciones estratégicas en los últimos meses, a medida que las empresas tratan de ampliar sus capacidades y hacer frente a la creciente demanda de una sólida protección digital. Cinco...

Latest transactions in the Consumer Software sector

El sector del Consumer software ha experimentado recientemente una dinámica oleada de adquisiciones que pone de relieve su evolución hacia la mejora de la participación de los usuarios y la ampliación de los servicios digitales. Entre las operaciones más destacadas...

Latest transactions in the Industrial Tech sector

El sector de la tecnología industrial ha sido testigo de una oleada de transacciones estratégicas en los últimos meses, señal de una rápida evolución y expansión. Entre las operaciones más destacadas, Bosch Energy and Building Solutions adquirió DMS Ettlingen para...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

Request for information

If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

Or if you prefer, call us at:

+34 946 42 41 42